These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31067495)

  • 21. [Effect of orlistat therapy on carbohydrate, lipid, vitamin and hormone plasma levels in obese subjects].
    Czerwieńska B; Kokot F; Franek E; Irzyniec T; Wiecek A
    Pol Arch Med Wewn; 2004 Dec; 112(6):1415-23. PubMed ID: 15962606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic and Natural Lipase Inhibitors.
    Bialecka-Florjanczyk E; Fabiszewska AU; Krzyczkowska J; Kurylowicz A
    Mini Rev Med Chem; 2018; 18(8):672-683. PubMed ID: 27484624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine.
    Sternby B; Hartmann D; Borgström B; Nilsson A
    Clin Nutr; 2002 Oct; 21(5):395-402. PubMed ID: 12381337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects.
    Vidgren HM; Agren JJ; Valve RS; Karhunen LJ; Rissanen AM; Uusitupa MI
    Clin Pharmacol Ther; 1999 Sep; 66(3):315-22. PubMed ID: 10511068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase.
    Kazmi I; Afzal M; Rahman S; Iqbal M; Imam F; Anwar F
    Eur J Pharmacol; 2013 Jun; 709(1-3):28-36. PubMed ID: 23500199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
    Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
    Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free Linoleic Acid and Oleic Acid Reduce Fat Digestion and Absorption In Vivo as Potent Pancreatic Lipase Inhibitors Derived from Sesame Meal.
    Li X; Morita S; Yamada H; Koga K; Ota W; Furuta T; Yamatsu A; Kim M
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
    Hill JO; Hauptman J; Anderson JW; Fujioka K; O'Neil PM; Smith DK; Zavoral JH; Aronne LJ
    Am J Clin Nutr; 1999 Jun; 69(6):1108-16. PubMed ID: 10357727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Obesity Effect of Arq Zeera and Its Main Components Thymol and Cuminaldehyde in High Fat Diet Induced Obese Rats.
    Haque MR; Ansari HS
    Drug Res (Stuttg); 2018 Nov; 68(11):637-647. PubMed ID: 29635674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-gamma-linolenin and tripalmitin in mice.
    Isler D; Moeglen C; Gains N; Meier MK
    Br J Nutr; 1995 Jun; 73(6):851-62. PubMed ID: 7632666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orlistat inhibits dietary cholesterol absorption.
    Mittendorfer B; Ostlund RE; Patterson BW; Klein S
    Obes Res; 2001 Oct; 9(10):599-604. PubMed ID: 11595776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of interesterified lipid design on the short/medium chain fatty acid hydrolysis rate and extent (in vitro).
    Acquistapace S; Patel L; Patin A; Forbes-Blom E; Cuenoud B; Wooster TJ
    Food Funct; 2019 Jul; 10(7):4166-4176. PubMed ID: 31241123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.
    Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT
    Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanostructuring Biomaterials with Specific Activities towards Digestive Enzymes for Controlled Gastrointestinal Absorption of Lipophilic Bioactive Molecules.
    Joyce P; Whitby CP; Prestidge CA
    Adv Colloid Interface Sci; 2016 Nov; 237():52-75. PubMed ID: 28314428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
    Fatouros DG; Bergenstahl B; Mullertz A
    Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactive Hybrid Particles from Poly(D,L-lactide-co-glycolide) Nanoparticle Stabilized Lipid Droplets.
    Joyce P; Whitby CP; Prestidge CA
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17460-70. PubMed ID: 26181279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Montmorillonite and Laponite Clay Materials for the Solidification of Lipid-Based Formulations for the Basic Drug Blonanserin: In Vitro and in Vivo Investigations.
    Dening TJ; Thomas N; Rao S; van Looveren C; Cuyckens F; Holm R; Prestidge CA
    Mol Pharm; 2018 Sep; 15(9):4148-4160. PubMed ID: 30067372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling the enzymatic digestion of lipids using hybrid nanostructured materials.
    Tan A; Colliat-Dangus P; Whitby CP; Prestidge CA
    ACS Appl Mater Interfaces; 2014 Sep; 6(17):15363-71. PubMed ID: 25116477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.